Document is current

Any future updates will be listed below

EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1186/s40425-018-0470-3

Published Online: 2019-01-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark